SYRE
Spyre Therapeutics, Inc. (SYRE) Earnings
Review Spyre Therapeutics, Inc. (SYRE) earnings with company data, supporting context and links to related investor research.
Research record updated: . Individual measures may refer to different reporting periods.
- Annual EPS
- -46.15
- Trailing EPS
- -1.95
- Annual revenue
- $886,000.00
- Trailing revenue
- $90.49M
- Next earnings date
- 2026-08-06
- Earnings data source
- S&P Global consensus via StockAnalysis + Finnhub earnings
Spyre Therapeutics, Inc. (SYRE) Earnings research
The SYRE earnings page organizes the available earnings-per-share and revenue context for Spyre Therapeutics, Inc.. Earnings trends are more informative when actual results are compared with prior periods, market expectations and management guidance.
Quarterly surprises can move a share price, but their long-term importance depends on margins, cash flow and the durability of demand. Continue to the financials and valuation pages for a broader view.